271980.KO
Jeil Pharmaceutical Co Ltd
9.830,00₩
-2,9 %
zum Vortag
Schlusskurs · Stand: 21. Aug 2026
Abschluss
GuV
Alle Werte je Aktie in KRW.
Zeilen ankreuzen und als Diagramm vergleichen (bis zu 4)
| Position | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | 11.443,85 | 11.689,62 | 11.929,23 | 11.854,77 | 11.834,61 | 11.667,68 | 12.013,39 | 12.437,49 | 11.844,83 | 12.341,63 | 13.359,71 | 12.086,36 | 11.765,60 | 13.111,22 | 12.247,85 | 12.161,10 | 12.330,09 | 11.695,13 | 11.884,75 | 11.967,22 | 12.803,53 | 11.187,85 | 9.445,02 | 9.248,26 | 8.965,13 | 8.860,89 | 36.349,78 | |
| – | – | – | – | 8.889,71 | 9.063,00 | 9.281,90 | 9.218,59 | 9.022,13 | 9.006,10 | 9.260,20 | 9.763,51 | 9.256,79 | 9.599,20 | 10.475,28 | 9.475,36 | 9.245,36 | 9.127,74 | 9.384,29 | 9.399,46 | 9.293,82 | 8.786,14 | 8.761,56 | 9.365,54 | 9.256,45 | 7.601,78 | 5.781,78 | 5.504,31 | 5.380,25 | 5.232,91 | 21.796,90 | |
| – | – | – | – | 2.554,14 | 2.626,62 | 2.647,33 | 2.636,19 | 2.812,48 | 2.661,58 | 2.753,19 | 2.673,97 | 2.588,04 | 2.742,43 | 2.884,43 | 2.611,01 | 2.520,24 | 3.983,48 | 2.863,56 | 2.761,64 | 3.036,26 | 2.908,99 | 3.123,20 | 2.601,68 | 3.547,08 | 3.586,06 | 3.663,24 | 3.743,96 | 3.584,88 | 3.627,98 | 14.552,88 | |
| – | – | – | – | 504,73 | 338,92 | 374,06 | 469,77 | 478,11 | 621,76 | 567,05 | 859,06 | 619,93 | 825,39 | 768,20 | 594,95 | 634,54 | 688,84 | 886,18 | 729,63 | 833,49 | 753,40 | 631,47 | 643,87 | 632,07 | 660,19 | 779,67 | 658,41 | 979,03 | 944,83 | 3.348,90 | |
| – | – | – | – | 1.101,19 | 1.117,08 | 1.150,59 | 1.270,47 | 1.278,49 | 2.715,76 | 1.420,58 | 2.846,40 | 1.340,74 | 1.208,42 | 1.320,07 | 1.281,38 | 1.310,85 | 1.306,01 | 1.332,09 | 1.296,69 | 1.313,91 | 1.363,67 | 1.329,27 | 1.376,65 | 1.610,32 | 1.489,34 | 1.561,35 | 1.456,73 | 1.507,81 | 1.583,55 | 6.082,06 | |
| – | – | – | – | 12.044,61 | 11.329,15 | 11.625,20 | 11.773,41 | 11.697,45 | 9.006,10 | 12.078,77 | 9.763,51 | 12.273,68 | 12.579,98 | 13.515,48 | 12.277,10 | 12.107,28 | 12.001,45 | 12.468,47 | 12.339,25 | 12.431,13 | 11.845,20 | 12.912,30 | 12.236,64 | 12.629,49 | 10.799,70 | 9.120,14 | 8.567,39 | 8.918,61 | 8.825,69 | 35.271,43 | |
| – | – | – | – | -600,76 | 360,48 | 304,03 | 81,36 | 137,16 | 2.661,58 | -65,38 | 2.673,97 | -428,85 | -238,35 | -155,77 | -190,73 | -341,69 | 1.109,77 | -220,62 | -178,15 | -101,05 | -150,07 | -1.027,55 | -269,42 | 174,04 | 388,14 | 324,88 | 680,87 | 46,52 | 35,20 | 1.078,35 | |
| – | – | – | – | 20,80 | 17,17 | 18,17 | 19,20 | 18,80 | 18,05 | 17,55 | 18,64 | 80,40 | 38,49 | 40,40 | 55,71 | 71,87 | 95,33 | 107,26 | 112,37 | 99,07 | 109,87 | 88,87 | 75,34 | 72,94 | 72,69 | 78,14 | 75,61 | 74,48 | 82,00 | 308,84 | |
| – | – | – | – | -686,90 | 388,76 | 263,39 | 73,52 | 133,26 | -95,11 | 197,29 | -16,93 | -1.032,31 | -273,96 | -105,33 | -263,15 | -266,39 | 998,58 | -83,60 | -309,41 | -474,07 | -202,46 | -1.566,83 | -366,10 | 285,29 | 327,43 | 251,83 | 1.215,39 | 598,41 | 219,93 | 2.272,25 | |
| – | – | – | – | 275,78 | 127,42 | 99,75 | 44,48 | 110,70 | 27,80 | 106,46 | 37,47 | -92,91 | 30,98 | 30,08 | 38,07 | – | – | 36,80 | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | -962,68 | 261,33 | 163,64 | 29,42 | 18,85 | -90,05 | 18,30 | -24,31 | -757,83 | -268,85 | -120,86 | -261,08 | -247,35 | 871,74 | -92,61 | -282,14 | -153,53 | -197,50 | -1.819,49 | -288,03 | 248,42 | 179,77 | 214,12 | 705,48 | 500,82 | -21,07 | 1.391,01 | |
| – | – | – | – | – | 558,87 | 281,56 | 246,37 | 304,34 | 2.661,58 | 370,60 | 2.673,97 | -793,51 | -89,23 | 86,16 | -53,61 | -35,96 | 1.254,59 | 192,09 | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = letzte zwölf Monate (Summe der jüngsten vier Quartale).
Datenstand: 21. August 2026 · Quelle: Fundamentaldaten & SEC-Berichte (Geschäfts- und Quartalsberichte, 10-K/10-Q)
Hinweis: reine Faktenanalyse, keine Anlageberatung und keine Aufforderung zum Kauf oder Verkauf. Angaben ohne Gewähr.